Explorer
Will we get nod for vaccine's emergency use? DCGI press conference at 11 am
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
India
Bharat Tiwari case: Chirag Paswan Visits Bharat Tiwari’s Family, Demands Justice Amid Bihar Encounter Row
Ram Temple donation case: SIT Widens Ayodhya Probe as Land Deals, Bank Records and Donation Assets Face Scrutiny
Ayodhya Ram Temple donation probe: RSS Breaks Silence, Calls for Tough Action in Ayodhya Temple Donation Probe
ALERT: Anti-Pakistan protests intensify in PoK as demonstrators demand rights and self-determination
Breaking: Bageshwar Dham chief calls alleged Ram Mandir donation theft a “major sin” in Ayodhya remarks
View More
Top Headlines
News
International Spiritual Council Urges World Leaders To Pursue Immediate Peace Resolution
News
Quote Of The Day: Nelson Mandela's Powerful Words On Achieving The Impossible
Trending
Russian Couple's Empire State Building Proposal Ends In Arrest: WATCH
Cities
Pune Fort Murder Case: Siya Goyal, Chetan Chaudhary Sent To 14-Day Judicial Custody
Trending News
